Nur Konyalilar

Dr. Nur Konyalilar

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 March 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
GGGizem Günes Günsel
Gizem Günes Günsel
TCThomas M. Conlon
Thomas M. Conlon
AJAicha Jeridi
Aicha Jeridi
RKRinho Kim
Rinho Kim
ZEZeynep Ertüz
Zeynep Ertüz
AYAli Önder Yildirim
Ali Önder Yildirim
Extravasation of monocytes into tissue and to the site of injury is a fundamental immunological process, which requires rapid responses via post translational modifications (PTM) of proteins. Protein arginine methyltransferase 7 (PRMT7) is an epigenetic factor that has the capacity to mono-methylate histones on arginine residues. Here we show that in chronic obstructive pulmonary disease (COPD) patients, PRMT7 expression is elevated in the lung tissue and localized to the macrophages. In mouse models of COPD, lung fibrosis and skin injury, reduced expression of PRMT7 associates with decreased recruitment of monocytes to the site of injury and hence less severe symptoms. Mechanistically, activation of NF-κB/RelA in monocytes induces PRMT7 transcription and consequential mono-methylation of histones at the regulatory elements of RAP1A, which leads to increased transcription of this gene that is responsible for adhesion and migration of monocytes. Persistent monocyte-derived macrophage accumulation leads to ALOX5 over-expression and accumulation of its metabolite LTB4, which triggers expression of ACSL4 a ferroptosis promoting gene in lung epithelial cells. Conclusively, inhibition of arginine mono-methylation might offer targeted intervention in monocyte-driven inflammatory conditions that lead to extensive tissue damage if left untreated.

24 October 2024 in Pulmonology
Verified
Journal Article
Open access
HBHasan Bayram
Hasan Bayram
NKNur Konyalilar
Nur Konyalilar
MEMuge Akpinar Elci
Muge Akpinar Elci
HRHadi Rajabi
Hadi Rajabi
GAG Tuşe Aksoy
G Tuşe Aksoy
GVGiovanni Viegi
Giovanni Viegi
Air pollution is a major global environment and health concern. Recent studies have suggested an association between air pollution and COVID-19 mortality and morbidity. In this context, a close association between increased levels of air pollutants such as particulate matter ≤2.5 to 10 µM, ozone and nitrogen dioxide and SARS-CoV-2 infection, hospital admissions and mortality due to COVID 19 has been reported. Air pollutants can make individuals more susceptible to SARS-CoV-2 infection by inducing the expression of proteins such as angiotensin converting enzyme (ACE)2 and transmembrane protease, serine 2 (TMPRSS2) that are required for viral entry into the host cell, while causing impairment in the host defence system by damaging the epithelial barrier, muco-ciliary clearance, inhibiting the antiviral response and causing immune dysregulation. The aim of this review is to report the epidemiological evidence on impact of air pollutants on COVID 19 in an up-to-date manner, as well as to provide insights on in vivo and in vitro mechanisms.

28 September 2019 in European Respiratory Journal
Verified
Conference Paper
Closed access
NKNur Konyalilar
Nur Konyalilar
AYAbdullah Burak Yıldız
Abdullah Burak Yıldız
DYDuygu Yazıcı
Duygu Yazıcı
HBHasan Bayram
Hasan Bayram
Increased oxidative stress, epithelial permeability and cell viability play an important role in the pathogenesis of chronic airway diseases such as asthma and chronic obstructive pulmonary disease. Studies suggest that short-chain fatty acids such as butyrate may have regulatory effects at cellular level. We have investigated effects of hydrogen peroxide (H2O2) and butyrate on cell viability and trans-epithelial electrical resistance (TEER) of A549 cell cultures. A549 cells were cultured on semi-permeable cell culture inserts, and treated with 0, 100, 300, 600 µM H2O2 or 0.3, 1, 3 mM butyrate. TEER was measured at T0, T2, T4, T6 and T24 hrs. Cell viability was studied at T24hrs and T48hrs using 3-(4, 5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) method. H2O2 (100µM) significantly increased TEER at T6hrs (median= 129.8 %, p<0.05), comparing to the control group (median= 115.3 %). In contrast, 600µM H2O2 caused a significant decrease in TEER at T24hrs (medians= 124.6 % vs 105.6 %, p<0.01). Butyrate did not cause any significant changes in the TEER of cell cultures. H2O2 (100-600 µM) significantly decreased cell viability at T24 and T48 hrs, as compared to the control group (p<0.01). Only the highest dose of butyrate (3mM) significantly suppressed cell viability at T24hrs (median optical density= 0.5675 vs 0.3275, p<0.01). Our findings demonstrate that H2O2 can decrease A549 cell viability, while increasing TEER, and that butyrate is non-toxic to the cells at lower concentrations used.

28 July 2024 in Viruses
Verified
Journal Article
Open access
PDF file
OKOzgecan Kayalar
Ozgecan Kayalar
PÇPelin Duru Çetinkaya
Pelin Duru Çetinkaya
VEVahap ELDEM
Vahap ELDEM
SBSerap Argun Baris
Serap Argun Baris
NKNurdan Kokturk
Nurdan Kokturk
HBHasan Bayram
Hasan Bayram
The multisystemic effects of COVID-19 may continue for a longer time period following the acute phase, depending on the severity of the disease. However, long-term systemic transcriptomic changes associated with COVID-19 disease and the impact of disease severity are not fully understood. We aimed to investigate the impact of COVID-19 and its severity on transcriptomic alterations in peripheral blood mononuclear cells (PBMCs) following 1 year of the disease. PBMCs were isolated from the peripheral blood of healthy control donors who did not have COVID-19 (C; n = 13), from COVID-19 patients without pneumonia (NP; n = 11), and from COVID-19 patients with severe pneumonia (SP; n = 10) after 1-year of follow-up. Following RNA isolation from PBMCs, high-quality RNAs were sequenced after creating a library. Differentially expressed genes (DEGs) and differentially expressed long non-coding RNAs (DElncRNAs) were identified using Benjamini–Hochberg correction and they were analysed for hierarchical clustering and principal component analysis (PCA). Intergroup comparisons (C vs. NP, C vs. SP, and NP vs. SP) of DEGs and DElncRNAs were performed and hub genes were determined. Functional enrichment analyses of DEGs and DElncRNAs were made using Metascape (v3.5.20240101) and the first version of NCPATH. The RNA sequencing analysis revealed 4843 DEGs and 1056 DElncRNAs in “C vs. NP”, 1651 DEGs and 577 DElncRNAs in “C vs. SP”, and 954 DEGs and 148 DElncRNAs in “NP vs. SP”, with 291 DEGs and 70 DElncRNAs shared across all groups, respectively. We identified 14 hub genes from 291 DEGs, with functional enrichment analysis showing upregulated DEGs mainly linked to inflammation and osteoclast differentiation and downregulated DEGs to viral infections and immune responses. The analysis showed that 291 common and 14 hub genes were associated with pneumonia and that these genes could be regulated by the transcription factors JUN and NFκB1 carrying the NFκB binding site. We also revealed unique immune cell signatures across DEG categories indicating that the upregulated DEGs were associated with neutrophils and monocytes, while downregulated DEGs were associated with CD4 memory effector T cells. The comparative transcriptomic analysis of NP and SP groups with 52 gene signatures suggestive of IPF risk showed a lower risk of IPF in the SP group than the NP patients. Our findings suggest that COVID-19 may cause long term pathologies by modulating the expression of various DEGs, DeLncRNAs, and hub genes at the cellular level.

27 August 2025
Verified
Book Chapter
Closed access
PDF file
NKNur Konyalilar
Nur Konyalilar
MAMuge Akpinar-Elci
Muge Akpinar-Elci
HBHasan Bayram
Hasan Bayram

14 December 2023 in medRxiv
Verified
Preprint
Open access
PDF file
OKOzgecan Kayalar
Ozgecan Kayalar
PÇPelin Duru Çetinkaya
Pelin Duru Çetinkaya
VEVahap ELDEM
Vahap ELDEM
SBSerap Argun Baris
Serap Argun Baris
NKNurdan Kokturk
Nurdan Kokturk
HBHasan Bayram
Hasan Bayram
Long-COVID-19 manifests as a multisystemic condition with varied symptoms lingering beyond three weeks of acute SARS-CoV-2 infection, though its underlying mechanisms remain elusive. Aiming to decipher the long-term molecular impacts of COVID-19, we conducted a transcriptomic analysis on PBMCs from 1-year post-covid patients, including individuals without pneumonia (NP, n=10), those with severe pneumonia (SP, n=11), and healthy controls (C, n=13). Our extensive RNA sequencing revealed 4843 differentially expressed genes (DEGs) and 1056 differentially expressed long non-coding RNAs (DElncRNAs) in “C vs NP,” 1651 DEGs and 577 DElncRNAs in “C vs SP,” 954 DEGs and 148 DElncRNAs in “NP vs SP,” with 291 DEGs and 70 DElncRNAs shared across all groups. We identified 14 hub genes from 291 DEGs, with functional enrichment analysis showing upregulated DEGs mainly linked to inflammation and osteoclast differentiation, and downregulated DEGs to viral infections and immune responses. These hub genes play central roles in inflammatory and immune processes and are significantly associated with pneumonitis and diverse lung diseases. Investigations revealed unique immune cell signatures across DEG categories, associating upregulated DEGs with neutrophils and monocytes, and downregulated DEGs with CD4 memory effector T cells. Analysis of 14 hub genes showed notable upregulation in the no pneumonia group versus healthy controls, displaying complex patterns in the severe pneumonia group. Our study uncovered potential idiopathic pulmonary fibrosis signals in Long-COVID-19 patients’ PBMC transcriptome, highlighting the urgency for thorough monitoring and extended research to understand COVID-19’s lasting effects. This study sheds light on COVID-19’s transcriptomic changes and potential lasting effects, guiding future research and therapeutic approaches for Long-COVID-19.